Episode 294: ASCO GU 2024 - Adjuvant Pembrolizumab in Bladder Cancer

Andrea Apolo, MD, discusses the phase III AMBASSADOR study that investigated adjuvant pembrolizumab against observation in patients with muscle-invasive urothelial carcinoma and locally advanced urothelial carcinoma.
Dr. Apolo is the senior investigator of the Genitourinary Malignancies Branch of the National Cancer Institute.